Clinical trial
Post-Marketing Surveillance of TISSUCOL for Hemostasis in Subjects Undergoing…
NCT00163592 · Baxter Healthcare Corporation, Industry · Completed
Key facts
| NCT number | NCT00163592 |
|---|---|
| Title | Post-Marketing Surveillance of TISSUCOL for Hemostasis in Subjects Undergoing Vascular Reconstruction With Polytetrafluoroethylene (PTFE) Prosthesis |
| Official title | Non- Interventional Study of Tissucol® for Hemostasis in Subjects With Femoral Vascular Anastomosis Undergoing Vascular Reconstruction With PTFE Prosthesis |
| Lead sponsor | Baxter Healthcare Corporation, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Femoral Vascular Anastomosis |
| Intervention type | Drug, Procedure |
| Interventions | Tissucol®, Control: Conventional treatment, i.e. compression with swabs |
| Enrollment | 60 |
| Start date | Sep 1, 2003 |
| Completion | Feb 1, 2004 |
| First posted | Sep 14, 2005 |
| Last update posted | Oct 23, 2006 |
| Countries | Austria, Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: